Steven R Laviolette
Overview
Explore the profile of Steven R Laviolette including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
93
Citations
2263
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee K, Sarikahya M, Cousineau S, Yeung K, Lucas A, Loudon K, et al.
Sci Rep
. 2025 Mar;
15(1):8316.
PMID: 40064971
Cannabis use in pregnancy is associated with low birthweight outcomes. Recent preclinical data suggests that maternal Δ9-tetrahydrocannabinol (THC) exposure leads to decreases in birthweight followed by early cardiac deficits in...
2.
Proud E, Rodriguez-Ruiz M, Gummerson D, Vanin S, Hardy D, Rushlow W, et al.
Front Pharmacol
. 2025 Jan;
15:1473213.
PMID: 39764466
Introduction: Prenatal nicotine exposure (PNE) from maternal smoking disrupts regulatory processes vital to fetal development. These changes result in long-term behavioral impairments, including mood and anxiety disorders, that manifest later...
3.
De Felice M, Szkudlarek H, Uzuneser T, Rodriguez-Ruiz M, Sarikahya M, Pusparajah M, et al.
Biol Psychiatry Glob Open Sci
. 2024 Sep;
4(6):100361.
PMID: 39257692
Background: Exposure to Δ-tetrahydrocannabinol (THC) is an established risk factor for later-life neuropsychiatric vulnerability, including mood- and anxiety-related symptoms. The psychotropic effects of THC on affect and anxiogenic behavioral phenomena...
4.
DeVuono M, Nashed M, Sarikahya M, Kocsis A, Lee K, Vanin S, et al.
Neurobiol Dis
. 2024 Jul;
199:106588.
PMID: 38960101
Clinical and preclinical evidence has demonstrated an increased risk for neuropsychiatric disorders following prenatal cannabinoid exposure. However, given the phytochemical complexity of cannabis, there is a need to understand how...
5.
Ng T, Sarikahya M, Hudson R, Szkudlarek H, Perez-Valenzuela E, Uzuneser T, et al.
Neuropsychopharmacology
. 2024 Mar;
49(7):1171-1182.
PMID: 38521861
The majority of lifetime smokers begin using nicotine during adolescence, a critical period of brain development wherein neural circuits critical for mood, affect and cognition are vulnerable to drug-related insults....
6.
Lee K, Vanin S, Nashed M, Sarikahya M, Laviolette S, Natale D, et al.
Cannabis Cannabinoid Res
. 2024 Feb;
9(3):781-796.
PMID: 38358335
Studies indicate that ∼7% of pregnant individuals in North America consume cannabis in pregnancy. Pre-clinical studies have established that maternal exposure to Δ-tetrahydrocannabinol (THC; major psychoactive component in cannabis) leads...
7.
Vanin S, Lee K, Nashed M, Tse B, Sarikahya M, Brar S, et al.
J Endocrinol
. 2023 Oct;
260(1).
PMID: 37855335
Reports in North America suggest that up to 20% of young women (18-24 years) use cannabis during pregnancy. This is concerning given clinical studies indicate that maternal cannabis use is...
8.
Jones M, Uzuneser T, Clement T, Wang H, Ojima I, Rushlow W, et al.
Psychopharmacology (Berl)
. 2023 Sep;
241(1):119-138.
PMID: 37747506
Rationale: The endocannabinoid (eCB) system critically controls anxiety and fear-related behaviours. Anandamide (AEA), a prominent eCB ligand, is a hydrophobic lipid that requires chaperone proteins such as Fatty Acid Binding...
9.
Perez-Valenzuela E, Hudson R, Uzuneser T, De Felice M, Szkudlarek H, Rushlow W, et al.
Curr Neuropharmacol
. 2023 Sep;
22(12):2059-2078.
PMID: 37702237
Cannabis has shown therapeutic potential in mood and anxiety-related pathologies. However, the two primary constituents of cannabis, cannabidiol (CBD) and Δ-9-tetrahydrocannabinol (THC) produce distinct effects on molecular pathways in neural...
10.
Sarikahya M, Cousineau S, De Felice M, Szkudlarek H, Wong K, DeVuono M, et al.
Mol Psychiatry
. 2023 Jul;
28(10):4234-4250.
PMID: 37525013
With increasing maternal cannabis use, there is a need to investigate the lasting impact of prenatal exposure to Δ9-tetrahydrocannabinol (THC), the main psychotropic compound in cannabis, on cognitive/memory function. The...